A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis
一项针对复发/难治性B细胞淋巴瘤的blinatumomab/来那度胺I期研究:毒性、疗效及相关性分析
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025016845
Tuscano, Joseph M; Othman, Tamer; Frankel, Paul; Ruel, Christopher; Poh, Christina; Herbert, Samantha; Maverakis, Emanual; Merleev, Alexander A; Luxardi, Guillaume; Abedi, Mehrdad; Ranganathan, Raghuveer; Modi, Dipenkumar; Zain, Jasmine; Budde, Elizabeth L; Mei, Matthew; Rosenberg, Aaron S; Hoeg, Rasmus T; Costello, Caitlin; Foss, Francine M; William, Basem M; Holland, H Kent; Sharon, Elad; Streicher, Howard; Danilov, Alexy; Newman, Edward